skip to main content

Catastrophic APS — ESENeph MCQ

Instant feedback + full explanation. One question, done properly.

HardGlomerulonephritisCatastrophic APSESENeph

A patient with primary IgA nephropathy is selected for targeted-release budesonide. Which complete first-course schedule matches the current Kinpeygo SmPC?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Take 16 mg before breakfast 9 months, then 8 mg for 2 weeks

Explanation lettering: D = shown as A · E = shown as C · A = shown as D · C = shown as E

E is correct. Kinpeygo is 16 mg once daily in the morning at least one hour before a meal for an initial nine-month course, followed by 8 mg once daily for two weeks when discontinuing; an additional 4 mg two-week step may be used at the clinician’s discretion. The formulation and ileal release profile make timing and capsule handling part of the regimen.

Reference: Kinpeygo 4 mg modified-release hard capsules SmPC: https://www.medicines.org.uk/emc/product/15393/smpc